Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic
The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Ca...
Gespeichert in:
Veröffentlicht in: | American journal of cancer research 2020-01, Vol.10 (8), p.2282-2292 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2292 |
---|---|
container_issue | 8 |
container_start_page | 2282 |
container_title | American journal of cancer research |
container_volume | 10 |
creator | Zhao, Wensi Qiu, Hu Gong, Yi Han, Chen Ruan, Shasha Wang, Chenyu Chen, Jiamei Ke, Shaobo Shi, Wei Wang, Jing Xu, Qiuni Li, Yan Shi, Yuxia Chen, Qian Chen, Yongshun |
description | The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7471365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2441601166</sourcerecordid><originalsourceid>FETCH-LOGICAL-p196t-6d2d1fe76892b03741452fd27b56d715f8bca01c8cbee585bba331484354ff053</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhisEYtPYX0A5cqmUNF_NBQmVr0mTdgGuUZomW1CblqRD4t-TsoGGL7bsx-9r-SybF4iynAnOzk_qWbaM8R2mIBAJIi6zGS4EpBSSeear1nmnVQt076NrTFCjSxWwfQDjzoBOebU1nfEj6C3QymsTwJCg1InA-QPkRrf9WQRxTPiETv1q87a6z5FIC74xndNX2YVVbTTLY15kr48PL9Vzvt48raq7dT4gwcacNUWDrOGsFEUNMSeI0MI2Ba8paziitqy1gkiXujaGlrSuFcaIlARTYi2keJHdHnSHfd2ZRqdjg2rlEFynwpfslZP_J97t5Lb_lJxwhNkkcHMUCP3H3sRRdi5q07bKm34fZUEIYhAhxhJ6fer1Z_L7ZPwNQN57nw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2441601166</pqid></control><display><type>article</type><title>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zhao, Wensi ; Qiu, Hu ; Gong, Yi ; Han, Chen ; Ruan, Shasha ; Wang, Chenyu ; Chen, Jiamei ; Ke, Shaobo ; Shi, Wei ; Wang, Jing ; Xu, Qiuni ; Li, Yan ; Shi, Yuxia ; Chen, Qian ; Chen, Yongshun</creator><creatorcontrib>Zhao, Wensi ; Qiu, Hu ; Gong, Yi ; Han, Chen ; Ruan, Shasha ; Wang, Chenyu ; Chen, Jiamei ; Ke, Shaobo ; Shi, Wei ; Wang, Jing ; Xu, Qiuni ; Li, Yan ; Shi, Yuxia ; Chen, Qian ; Chen, Yongshun</creatorcontrib><description>The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.</description><identifier>ISSN: 2156-6976</identifier><identifier>EISSN: 2156-6976</identifier><identifier>PMID: 32905504</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Review</subject><ispartof>American journal of cancer research, 2020-01, Vol.10 (8), p.2282-2292</ispartof><rights>AJCR Copyright © 2020.</rights><rights>AJCR Copyright © 2020 2020</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471365/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471365/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32905504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Wensi</creatorcontrib><creatorcontrib>Qiu, Hu</creatorcontrib><creatorcontrib>Gong, Yi</creatorcontrib><creatorcontrib>Han, Chen</creatorcontrib><creatorcontrib>Ruan, Shasha</creatorcontrib><creatorcontrib>Wang, Chenyu</creatorcontrib><creatorcontrib>Chen, Jiamei</creatorcontrib><creatorcontrib>Ke, Shaobo</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Xu, Qiuni</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Shi, Yuxia</creatorcontrib><creatorcontrib>Chen, Qian</creatorcontrib><creatorcontrib>Chen, Yongshun</creatorcontrib><title>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</title><title>American journal of cancer research</title><addtitle>Am J Cancer Res</addtitle><description>The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.</description><subject>Review</subject><issn>2156-6976</issn><issn>2156-6976</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhisEYtPYX0A5cqmUNF_NBQmVr0mTdgGuUZomW1CblqRD4t-TsoGGL7bsx-9r-SybF4iynAnOzk_qWbaM8R2mIBAJIi6zGS4EpBSSeear1nmnVQt076NrTFCjSxWwfQDjzoBOebU1nfEj6C3QymsTwJCg1InA-QPkRrf9WQRxTPiETv1q87a6z5FIC74xndNX2YVVbTTLY15kr48PL9Vzvt48raq7dT4gwcacNUWDrOGsFEUNMSeI0MI2Ba8paziitqy1gkiXujaGlrSuFcaIlARTYi2keJHdHnSHfd2ZRqdjg2rlEFynwpfslZP_J97t5Lb_lJxwhNkkcHMUCP3H3sRRdi5q07bKm34fZUEIYhAhxhJ6fer1Z_L7ZPwNQN57nw</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Zhao, Wensi</creator><creator>Qiu, Hu</creator><creator>Gong, Yi</creator><creator>Han, Chen</creator><creator>Ruan, Shasha</creator><creator>Wang, Chenyu</creator><creator>Chen, Jiamei</creator><creator>Ke, Shaobo</creator><creator>Shi, Wei</creator><creator>Wang, Jing</creator><creator>Xu, Qiuni</creator><creator>Li, Yan</creator><creator>Shi, Yuxia</creator><creator>Chen, Qian</creator><creator>Chen, Yongshun</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</title><author>Zhao, Wensi ; Qiu, Hu ; Gong, Yi ; Han, Chen ; Ruan, Shasha ; Wang, Chenyu ; Chen, Jiamei ; Ke, Shaobo ; Shi, Wei ; Wang, Jing ; Xu, Qiuni ; Li, Yan ; Shi, Yuxia ; Chen, Qian ; Chen, Yongshun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p196t-6d2d1fe76892b03741452fd27b56d715f8bca01c8cbee585bba331484354ff053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Wensi</creatorcontrib><creatorcontrib>Qiu, Hu</creatorcontrib><creatorcontrib>Gong, Yi</creatorcontrib><creatorcontrib>Han, Chen</creatorcontrib><creatorcontrib>Ruan, Shasha</creatorcontrib><creatorcontrib>Wang, Chenyu</creatorcontrib><creatorcontrib>Chen, Jiamei</creatorcontrib><creatorcontrib>Ke, Shaobo</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Xu, Qiuni</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Shi, Yuxia</creatorcontrib><creatorcontrib>Chen, Qian</creatorcontrib><creatorcontrib>Chen, Yongshun</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Wensi</au><au>Qiu, Hu</au><au>Gong, Yi</au><au>Han, Chen</au><au>Ruan, Shasha</au><au>Wang, Chenyu</au><au>Chen, Jiamei</au><au>Ke, Shaobo</au><au>Shi, Wei</au><au>Wang, Jing</au><au>Xu, Qiuni</au><au>Li, Yan</au><au>Shi, Yuxia</au><au>Chen, Qian</au><au>Chen, Yongshun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</atitle><jtitle>American journal of cancer research</jtitle><addtitle>Am J Cancer Res</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>10</volume><issue>8</issue><spage>2282</spage><epage>2292</epage><pages>2282-2292</pages><issn>2156-6976</issn><eissn>2156-6976</eissn><abstract>The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>32905504</pmid><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2156-6976 |
ispartof | American journal of cancer research, 2020-01, Vol.10 (8), p.2282-2292 |
issn | 2156-6976 2156-6976 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7471365 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Review |
title | Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20considerations%20for%20the%20management%20of%20cancer%20patients%20in%20the%20mitigation%20stage%20of%20the%20COVID-19%20pandemic&rft.jtitle=American%20journal%20of%20cancer%20research&rft.au=Zhao,%20Wensi&rft.date=2020-01-01&rft.volume=10&rft.issue=8&rft.spage=2282&rft.epage=2292&rft.pages=2282-2292&rft.issn=2156-6976&rft.eissn=2156-6976&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2441601166%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2441601166&rft_id=info:pmid/32905504&rfr_iscdi=true |